VisEn's in vivo fluorescence imaging technologies, including its Fluorescence Agent Portfolio and its Fluorescence Molecular Tomographic (FMTTM) Imaging Systems provide robust fluorescence molecular imaging performance in identifying, characterizing and quantifying ranges of disease biomarkers and therapeutic efficacy in vivo. VisEn's FMT systems and agents are used by leading research institutions and pharmaceutical companies in applications including cancer research, inflammation, cardiovascular, skeletal and pulmonary disease. The company also works with large pharmaceutical partners to design ranges of tailored molecular imaging agents and applications that are designed to their specific pre-clinical and clinical research areas.

Beijing Shihong Pharmaceutical Co., Ltd., established on 1996-09-03, The scope of business includes the production of chemical pharmaceuticals;to develop,Sales of radiopharmaceuticals(in vivo);technology development;retail medicine;wholesale medicine;sell food.(Market entities independently choose business projects in accordance with the law,Carry out business activities;sell food,wholesale medicine,Retail pharmaceuticals and items subject to legal approval,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Verily aspires to create a world in which technology and life sciences are not distinct, but partners with a united mission. Formerly Google Life Sciences, Verily's mission is to bring together technology and life sciences to uncover new truths about health and disease. Verily's multidisciplinary teams have access to advanced research tools, large-scale computing power, and unique technical expertise. They work with partners from across the industry and many fields of research to develop new technology, launch studies and start companies. The company was founded in 2015 and is based in San Francisco, California, United States.

London Health Sciences Centre Research, Inc. (doing business as Lowson Health Research Institute) is a private company headquartered in Canada. The firm operates as a hospital.

Poseida Therapeutics is a clinical-stage biopharmaceutical company utilizing genome engineering capabilities to develop targeted therapeutics for patients with high unmet medical needs. The company develops a pipeline of autologous and allogeneic chimeric antigen receptor T cell or CAR-T, product candidates focusing on the treatment of hematological malignancies and solid tumors. Poseida Therapeutics was founded in 2014 and is headquartered in San Diego, California.

Academisch Ziekenhuis Maastricht operates as medical research centre. The company is headquartered in Maastricht, the Netherlands.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Vindico NanoBioTechnology LLC develops novel and life-saving therapies. The company is headquartered in San Diego, CA.

Shenzhen Hanguang Technology Co., Ltd., established on 2018-12-05, Business scope includes general business items:Optoelectronic devices,R&D and sales of optoelectronic products such as lasers;Technology development services for new nanomaterials;Domestic Trade;Operating import and export business.Cloud Computing Equipment Manufacturing;Cloud Computing Equipment Sales;Cloud Computing Equipment Technical Services;internet data service;Industrial Internet Data Service;Artificial intelligence basic software development;Artificial intelligence application software development;software development;Internet of things technology research and development;Internet of Things Technology Services;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Wholesale of computer software, hardware and auxiliary equipment;Network and Information Security Software Development;Software outsourcing service;data processing services;Manufacturing of electronic components;Manufacturing of electronic components and electromechanical components;Marine environmental monitoring and detection equipment manufacturing;Household Appliance Manufacturing;IoT device manufacturing;Manufacturing of Semiconductor Discrete Devices;integrated circuit manufacturing.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license),The licensing program is:R&D and sales of biomedicine based on new two-dimensional materials.Production of Class II Medical Devices;Production of Class III Medical Devices.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Guangdong General Hospital (Chinese: 广东省人民医院 meaning "Guangdong Provincial People's Hospital") is a large hospital, founded in 1946, located in Yuexiu District, Guangzhou, Guangdong, China.

Nanjing Drum Tower Hospital is a private company headquartered in China. The firm provides medical services.

Suzhou Baimai Biopharmaceutical Co. Ltd. is a Chinese company that manufactures pharmaceutical products.

Humanitas Mirasole SpA provides healthcare services. It offers oncology, cardiology, diagnostic, orthopaedic, dental, chest, vascular, plastic surgery, asthma care, and gynaecology treatments. The company is headquartered in Rozzano, Italy.

Nanjing Congyi Pharmaceutical Technology Co., Ltd., established on 2006-07-04, Business scope includes medical technology development and transfer,Medical Technology Services,Medical Consulting Services;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export);clinical research(Does not include diagnosis and treatment);Development and transfer of new medical technologies.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Omniox is a biopharmaceutical company developing new medicines for hypoxic diseases. Hypoxia, defined as insufficient levels of oxygen in tissues, is known to trigger or impact a range of serious illnesses and conditions including many cancers, cardiovascular diseases, and trauma. At the center of Omniox’ work is a protein-based platform technology (H-NOX), that is engineered to reverse hypoxic disease states by delivering oxygen or nitric oxide preferentially to hypoxic tissues.